INFINT Acquisition Corporation Announces Intention to Voluntarily Delist from NYSE, Conditional Upon Consummation of its Pending Business Combination with Seamless Group Inc.
August 14, 2024 16:15 ET
|
INFINT Acquisition Corporation
NEW YORK, NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) -- INFINT Acquisition Corporation (the “Company”) today announced that, in connection with its proposed business combination (the “Business...
Assembly Software Wins “Practice Management Innovation Of The Year” In 2023 LegalTech Breakthrough Awards Program
November 28, 2023 08:00 ET
|
LegalTech Breakthrough
LOS ANGELES, Nov. 28, 2023 (GLOBE NEWSWIRE) -- LegalTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout legal technology companies,...
Lexion Garners Prestigious Award In 2023 LegalTech Breakthrough Awards Program
November 16, 2023 08:03 ET
|
LegalTech Breakthrough
LOS ANGELES, Nov. 16, 2023 (GLOBE NEWSWIRE) -- LegalTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout legal technology companies,...
QSR Automations Partners on API Integration with Long Range Systems for Seamless Restaurant Operations
December 20, 2017 08:00 ET
|
Long Range Systems, LLC; QSR Automations
DALLAS, Dec. 20, 2017 (GLOBE NEWSWIRE) -- QSR Automations and Long Range Systems (LRS) have partnered to integrate LRS’ paging and tracking technologies with QSR’s kitchen management solutions. This...
Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting
December 12, 2017 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) "Cyclacel" or the "Company"), a biopharmaceutical company developing oral...
Cyclacel Pharmaceuticals Announces That Full Results From the Phase 3 Seamless Trial Have Been Selected for Oral Presentation at ASH 2017 Annual Meeting
November 01, 2017 09:02 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) (Cyclacel or the Company), a clinical-stage biopharmaceutical company using cell...
Drone Guarder, Inc. Announces Version 2.0 Operating System For Seamless Functionality with their Apps
September 12, 2017 08:30 ET
|
DroneGuarder Inc.
LONDON, Sept. 12, 2017 (GLOBE NEWSWIRE) -- Drone Guarder, Inc. (OTCQB:DRNG) The Drone Guarder software and app development team have completed Version 2.0 of the DG Operating System, which...
Cyclacel Announces Top-Line Results From Pivotal Phase 3 SEAMLESS Study in Elderly Patients With Acute Myeloid Leukemia
February 23, 2017 06:57 ET
|
Cyclacel
- Study did not reach statistically significant improvement in the primary endpoint of overall survival -- Improvement in secondary endpoint of complete remission rate for the experimental arm --...
Cyclacel Announces Publication of Phase 2 Results for Sapacitabine in Elderly AML Patients in the Lancet Oncology
November 01, 2012 07:00 ET
|
Cyclacel Pharmaceuticals, Inc.
Study Provides Support for SEAMLESS, an Ongoing, Phase 3, Registration-Directed Trial in Elderly Patients With Newly Diagnosed AML
Updated Survival Data From a Pilot Study and Lead-In Phase of...
Photo Release -- Barely There(R) Intimate Apparel Introduces the Get Cozy(TM) Bra
September 27, 2012 08:39 ET
|
Hanesbrands Inc. (hanes.com & championusa.com)
WINSTON-SALEM, N.C., Sept. 27, 2012 (GLOBE NEWSWIRE) -- When Barely There Intimate Apparel asked women in a national survey to describe their ideal bra, more than 65 percent of respondents said they...